We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $69.9B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+22.19%
3 Year Est. Return
+69.97%
5 Year Est. Return
10 Year Est. Return
AUM
$56.2B
AUM Growth
+$1.8B
Cap. Flow
+$5.21B
Cap. Flow %
9.28%
Top 10 Hldgs %
21.35%
Holding
2,399
New
146
Increased
921
Reduced
1,050
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 11.07%
3 Financials 10.51%
4 Industrials 7.72%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFF icon
2251
Village Farms International
VFF
$235M
$25.4K ﹤0.01%
20,500
AVAH icon
2252
Aveanna Healthcare
AVAH
$2.06B
$24.9K ﹤0.01%
10,000
TCON
2253
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$24.7K ﹤0.01%
2,873
XERS icon
2254
Xeris Biopharma Holdings
XERS
$1.44B
$24.3K ﹤0.01%
+11,000
New +$28.5K
LLAP
2255
DELISTED
Terran Orbital Corporation
LLAP
$23.1K ﹤0.01%
17,625
BDSX icon
2256
Biodesix
BDSX
$228M
$22.2K ﹤0.01%
775
TMC icon
2257
TMC The Metals Company
TMC
$1.59B
$21.5K ﹤0.01%
+15,050
New +$21K
CLNN icon
2258
Clene
CLNN
$68.9M
$21.3K ﹤0.01%
2,500
KPTI icon
2259
Karyopharm Therapeutics
KPTI
$168M
$21K ﹤0.01%
927
-6
-0.6% -$105
QVCGA
2260
DELISTED
QVC Group Inc Series A
QVCGA
$20.5K ﹤0.01%
334
+9
+3% +$471
QBTS icon
2261
D-Wave Quantum
QBTS
$6B
$20.4K ﹤0.01%
10,000
BETR icon
2262
Better Home & Finance Holding
BETR
$412M
$20.1K ﹤0.01%
809
-193
-19% -$5.41K
PFIE
2263
DELISTED
Profire Energy, Inc
PFIE
$18.5K ﹤0.01%
10,000
PMVP icon
2264
PMV Pharmaceuticals
PMVP
$66.1M
$17K ﹤0.01%
10,000
NKLA
2265
DELISTED
Nikola Corporation Common Stock
NKLA
$13.9K ﹤0.01%
446
+20
+5% +$429
ORGN
2266
DELISTED
Origin Materials
ORGN
$11.1K ﹤0.01%
723
THM
2267
International Tower Hill Mines
THM
$534M
$8.62K ﹤0.01%
12,500
MAPSW
2268
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$8.51K ﹤0.01%
130,988
+20,000
+18% +$878
LFLYW
2269
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$5.05K ﹤0.01%
162,846
NCPL icon
2270
Netcapital
NCPL
$3.15M
$1.25K ﹤0.01%
143
DNA.WS
2271
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$1.2K ﹤0.01%
13,300
PFTAW
2272
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$552 ﹤0.01%
+12,264
New +$698
VRMEW
2273
DELISTED
VerifyMe, Inc. Warrant
VRMEW
$400 ﹤0.01%
10,000
ACTG icon
2274
Acacia Research
ACTG
$450M
-37,000
Closed -$145K
ALGT icon
2275
Allegiant Air
ALGT
$2.64B
-2,527
Closed -$209K

Similar funds

Corient Private Wealth's Q1 2024 Portfolio in Review

As of Q1 2024, Corient Private Wealth held 2,399 positions worth $56.2B, up 3.3% from $54.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Corient Private Wealth deployed $5.21B of net new capital in Q1 2024, opening 146 new positions and adding to 921 existing holdings. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $165M trimmed.

  • Corient Private Wealth's largest Q1 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.
  • Corient Private Wealth added most to Berkshire Hathaway Class A in Q1 2024, an estimated $5.82B increase.
  • Corient Private Wealth's biggest Q1 2024 reduction was Apple, cutting an estimated $165M.
  • Corient Private Wealth fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $21.7M.
  • Corient Private Wealth's ten largest holdings make up 21% of its $56.2B portfolio in Q1 2024.
  • Corient Private Wealth opened 146 new positions and closed 123 in Q1 2024.
  • Corient Private Wealth's portfolio value rose 3.3% quarter-over-quarter to $56.2B.

Based on Corient Private Wealth's 13F filing for Q1 2024, filed 9 May 2024.